Belharra Therapeutics

company

About

Belharra Therapeutics is a small molecule discovery company founded by pioneers in the field of chemical biology.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$50M
Industries
Biotechnology,Chemical,Therapeutics
Founded date
Jan 1, 2021
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Belharra Therapeutics has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Jan 4, 2023 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 4, 2023 Series A $50M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Belharra Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A